Millennium Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Millennium Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,000	Closed	-$1.16M	–	6313
2023 Q1	$1.16M	Sell	30,000 -50,000	-63%	-$2.06M	﹤0.01%	3953
2022 Q4	$3.55M	Buy	+80,000	New	+$3.37M	﹤0.01%	3088

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management's LKFT Position: Q1 2026 in Review

Millennium Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 68% in Q1 2026, selling an estimated $7.66M and leaving 107,912 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3400.

Millennium Management first reported a position in LKFT in Q2 2015 and has held it in 35 quarters since. The position peaked at $19.5M in Q1 2022. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Millennium Management held 107,912 shares of Lakefront Biotherapeutics American Depositary Shares worth $3.24M as of Q1 2026.
Millennium Management sold 231,442 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $7.66M.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3400 holding.
Millennium Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and has held it in 35 quarters since.
Millennium Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $19.5M in Q1 2022.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.